AZ32 250mg | ≥99%
CSNpharm
AZ32
Search Results
NBQX 100mg | ≥99%
CSNpharm
NBQX is a potent, selective and competitive AMPAR antagonist, which shows activity of neuroprotective and anticonvulsant.
More Information Supplier PageNBQX
KG-501 10mg | ≥99%
CSNpharm
KG-501 is histochemical substrate of alkaline phosphatases and can inhibit CREB-CBP interaction.
More Information Supplier PageKG-501
KG-501 5mg | ≥99%
CSNpharm
KG-501 is histochemical substrate of alkaline phosphatases and can inhibit CREB-CBP interaction.
More Information Supplier PageKG-501
KG-501 50mg | ≥99%
CSNpharm
KG-501 is histochemical substrate of alkaline phosphatases and can inhibit CREB-CBP interaction.
More Information Supplier PageKG-501
INF39 100mg | ≥99%
CSNpharm
INF39 is an irreversible NLRP3 inhibitor with IC50 value of ~100 μM for inhibiton of NLRP3 ATPase, which can inhibit IL-1β release, caspase activation and pyroptosis in THP-1 cells.
More Information Supplier PageINF39
INF39 25mg | ≥99%
CSNpharm
INF39 is an irreversible NLRP3 inhibitor with IC50 value of ~100 μM for inhibiton of NLRP3 ATPase, which can inhibit IL-1β release, caspase activation and pyroptosis in THP-1 cells.
More Information Supplier PageINF39
INF39 2mg | ≥99%
CSNpharm
INF39 is an irreversible NLRP3 inhibitor with IC50 value of ~100 μM for inhibiton of NLRP3 ATPase, which can inhibit IL-1β release, caspase activation and pyroptosis in THP-1 cells.
More Information Supplier PageINF39
INF39 50mg | ≥99%
CSNpharm
INF39 is an irreversible NLRP3 inhibitor with IC50 value of ~100 μM for inhibiton of NLRP3 ATPase, which can inhibit IL-1β release, caspase activation and pyroptosis in THP-1 cells.
More Information Supplier PageINF39
INF39 5mg | ≥99%
CSNpharm
INF39 is an irreversible NLRP3 inhibitor with IC50 value of ~100 μM for inhibiton of NLRP3 ATPase, which can inhibit IL-1β release, caspase activation and pyroptosis in THP-1 cells.
More Information Supplier PageINF39